James Edgemond
2020
In 2020, James Edgemond earned a total compensation of $3.2M as Chief Financial Officerand Treasurer at United Therapeutics, a 80% decrease compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $1,790,415 |
|---|---|
| Non-Equity Incentive Plan | $677,250 |
| Salary | $722,115 |
| Other | $20,000 |
| Total | $3,209,780 |
Edgemond received $1.8M of change in pension value and nonqualified deferred compensation earnings, accounting for 56% of the total pay in 2020.
Edgemond also received $677.3K in non-equity incentive plan, $722.1K in salary and $20K in other compensation.
Rankings
In 2020, James Edgemond's compensation ranked 3,626th out of 13,090 executives tracked by ExecPay. In other words, Edgemond earned more than 72.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,626 out of 13,090 | 72nd |
Division Manufacturing | 1,421 out of 5,620 | 75th |
Major group Chemicals And Allied Products | 535 out of 2,253 | 76th |
Industry group Drugs | 465 out of 1,953 | 76th |
Industry Pharmaceutical Preparations | 351 out of 1,458 | 76th |
Source: SEC filing on April 29, 2022.
Edgemond's colleagues
We found three more compensation records of executives who worked with James Edgemond at United Therapeutics in 2020.